CREATION was born nearly two decades ago in 1998. Since that time we have advised some of the biggest and best names in healthcare, providing a range of services and products, all centered around adding value through engagement for the health and pharmaceutical industries.
In 2012 we developed CREATION Pinpoint in response to a client’s question about the views of online healthcare professionals. After beta testing with three major pharmaceutical brands revealed unique customer insights, the development of this exciting product, to hear and understand what healthcare professionals are saying online, became the core of our offering.
As Creation Healthcare, we had spent years educating and informing on how healthcare professionals were using the Internet and in latter years social media, and now we had the technology to support our great team.
Since 2013, the product has continued to see significant innovation and growth through our commitment to research and development and our in-house technology team.
With more than a million social media profiles worldwide, and more than a billion posts, CREATION Pinpoint leads the world in learning from healthcare professionals on public social media, to enable healthcare companies and organisations to be more effective.
Through CREATION Pinpoint, we now deliver studies for 70% of the world’s largest pharmaceutical companies, as well as global health organisations and academic bodies. Our research has thus far spanned over 180 countries and we have an ever-growing team of world-class experts in data analysis, healthcare, technology and marketing, as well as many international associate consultants who offer local knowledge to help serve our clients’ needs.
From our global offices in London, New York and our rural location in Maidstone, Kent, we love to meet with clients and those interested in our work, and to connect with others who share our vision and values.
If you would like to find out more about us or would like to speak to us about a study or potential career with CREATION, please do get in touch.